A recent study in NSCLC also demonstrated that the CD8+ T-cell infiltration was lower in liver metastases compared to other metastatic lesions and that combined PD-L1 TPS ≥ 1% and CD8+ T-cell infiltration in liver metastases increased PFS [48]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.